Differentiation of prostate cancer from normal prostate tissue: Role of hotspots in pharmacokinetic MRI and histologic evaluation

American Journal of Roentgenology

Volumn 194, Issue 3, 2010, Pages 675-681

  Franiel, Tobias ^a   Lüdemann, Lutz ^a   Rudolph, Birgit ^a   Lutterbeck, Eva ^a   Hamm, Bernd ^a   Beyersdorff, Dirk ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Blood volume; Hotspot; Perfusion; Pharmacokinetic MRI; Prostate cancer

Indexed keywords

CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; BLOOD VOLUME; CONTRAST ENHANCEMENT; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER;

AGED; ALGORITHMS; BIOPSY; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; DISCRIMINANT ANALYSIS; GADOLINIUM DTPA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; ROC CURVE;

EID: 77749277519     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.09.3233     Document Type: Article

References (28)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58:71-96
2. Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989; 339:58-61
3. Bigler SA, Deering RE, Brawer MK. Comparison of microscopic vascularity in benign and malignant prostate tissue. Hum Pathol 1993; 24:220-226
4. Jager GJ, Ruijter ET, van de Kaa CA, et al. Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. Radiology 1997; 203:645-652
5. Engelbrecht MR, Huisman HJ, Laheij RJ, et al. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology 2003; 229:248-254
6. Lüdemann L, Prochnow D, Rohlfing T, et al. Simultaneous quantification of perfusion and permeability in the prostate using dynamic contrastenhanced magnetic resonance imaging with an inversion-prepared dual-contrast sequence. Ann Biomed Eng 2009; 37:749-762
7. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999; 10:223-232
8. Futterer JJ, Heijmink SW, Scheenen TW, et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 2006; 241:449-458
9. Ocak I, Bernardo M, Metzger G, et al. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters. AJR 2007; 189:849; [web]W192-W201
10. Franiel T, Lüdemann L, Rudolph B, et al. Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence. Invest Radiol 2008; 43:481-487
11. Siegal JA, Yu E, Brawer MK. Topography of neovascularity in human prostate carcinoma. Cancer 1995; 75:2545-2551
12. Prochnow D, Beyersdorff D, Warmuth C, Taupitz M, Gemeinhardt O, Lüdemann L. Implementation of a rapid inversion-prepared dual-contrast gradient echo sequence for quantitative dynamic contrast-enhanced magnetic resonance imaging of the human prostate. Magn Reson Imaging 2005; 23:983-990
13. Griswold MA, Jakob PM, Chen Q, et al. Resolution enhancement in single-shot imaging using simultaneous acquisition of spatial harmonics (SMASH). Magn Reson Med 1999; 41:1236-1245
14. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993; 143:401-409
15. Rohlfing T, Russakoff DB, Denzler J, Mori K, Maurer CR. Progressive attenuation fields: fast 2D-3D image registration without precomputation. Med Phys 2005; 32:2870-2880
16. Calamante F, Gadian DG, Connelly A. Delay and dispersion effects in dynamic susceptibility contrast MRI: simulations using singular value decomposition. Magn Reson Med 2000; 44:466-473
17. Kershaw LE, Buckley DL. Precision in measurements of perfusion and microvascular permeability with T1-weighted dynamic contrast-enhanced MRI. Magn Reson Med 2006; 56:986-992
18. Franiel T, Lüdemann L, Rudolph B, et al. Prostate MR imaging: tissue characterization with pharmacokinetic volume and blood flow parameters and correlation with histologic parameters. Radiology 2009; 2009; 252:101-108
19. Franiel T, Lüdemann L, Taupitz M, Rost J, Asbach P, Beyersdorff D. Pharmacokinetic MRI of the prostate: parameters for differentiating lowgrade and high-grade prostate cancer [in German]. Rofo 2009; 181:536-542
20. Stamey TA, Freiha FS, McNeal JE, Redwine EA, Whittemore AS, Schmid HP. Localized prostate cancer: relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 1993; 71:933-938
21. Hricak H, Choyke PL, Eberhardt SC, Leibel SA, Scardino PT. Imaging prostate cancer: a multidisciplinary perspective. Radiology 2007; 243:28-53
22. Kurhanewicz J, Vigneron DB, Hricak H, Narayan P, Carroll P, Nelson SJ. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. Radiology 1996; 198:795-805
23. Issa B. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging. J Magn Reson Imaging 2002; 16:196-200
24. Mazaheri Y, Shukla-Dave A, Hricak H, et al. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging-correlation with pathologic findings. Radiology 2008; 246:480-488
25. Buckley DL, Roberts C, Parker GJ, Logue JP, Hutchinson CE. Prostate cancer: evaluation of vascular characteristics with dynamic contrastenhanced T1-weighted MR imaging-initial experience. Radiology 2004; 233:709-715
26. van Dorsten FA, van der Graaf M, Engelbrecht MR, et al. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer. J Magn Reson Imaging 2004; 20:279-287
27. Gemeinhardt O. Functional imaging of the vascularization and perfusion of prostate cancer with dynamic MRI. In: Veterinärmedizin. Berlin, Germany: Freie Universität Berlin, 2008:153
28. Borre M, Offersen BV, Nerstrom B, Overgaard J. Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting. Br J Cancer 1998; 78:940-944